Skip to content

APOTHEEK COLLA-ACKX: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

APOTHEEK COLLA-ACKX

BE 0434.122.906
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€190,588
2024 · €226,227-€35,639
Equity
€257,232
2024 · €257,232
Cash
€287,095
2024 · €456,788-€169,694
Balance sheet total
€1.2m
2024 · €904,109+€291,822

Largest movements

2024 to 2025
Assets
  • Tangible fixed assets +€436,168

    up €436,168 (+1,919%), from €22,731 to €458,898

    of which Plant, machinery and equipment: +€437,301

  • Cash -€169,694

    down €169,694 (-37.1%), from €456,788 to €287,095

    mainly Investment in fixed assets (net) (-€464,651) and Contributions, distributions and other (-€190,588)

  • Receivables within one year +€36,418

    up €36,418 (+13.2%), from €276,327 to €312,745

    of which Other amounts receivable: +€39,366

Equity and liabilities
  • Other debts +€297,884

    up €297,884 (+58.5%), from €509,617 to €807,501

Income statement
  • Gross operating margin -€30,622

    down €30,622 (-8.5%), from €361,133 to €330,511

  • Staff costs -€16,938

    down €16,938 (-18.0%), from €93,863 to €76,925

  • Depreciation +€15,439

    up €15,439 (+118%), from €13,045 to €28,483

  • Taxes +€6,224

    up €6,224 (+26.8%), from €23,240 to €29,463

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €226,227
Gross operating margin -€30,622
Staff costs +€16,938
Depreciation -€15,439
Other operating charges +€9
Financial income -€483
Financial charges +€182
Taxes -€6,224
Result 2025 €190,588
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations +€490,677
Investment -€464,651
Financing -€195,720
Cash 2024 €456,788
Net result for the year +€190,588
Depreciation +€28,483
Stocks and contracts +€1,999
Receivables within one year -€36,418
Deferred charges and accrued income +€9,071
Trade debts -€779
Tax, wage and social debts -€1,663
Other debts +€297,884
Accrued charges and deferred income +€1,511
Investment in fixed assets (net) -€464,651
Current portion of long-term debt -€5,131
Contributions, distributions and other -€190,588
Cash 2025 €287,095
brings cash intakes cash out
Every line side by side 49 lines
Line Code 2024 2025 Change %
Total assets 20/58 €904,109 €1,195,931 +€291,822 +32.3%
Fixed assets 21/28 €22,731 €458,898 +€436,168 +1,919%
Tangible fixed assets 22/27 €22,731 €458,898 +€436,168 +1,919%
Land and buildings 22 €9,229 €6,141 -€3,088 -33.5%
Plant, machinery and equipment 23 €6,335 €443,636 +€437,301 +6,903%
Furniture and vehicles 24 €7,166 €9,121 +€1,955 +27.3%
Current assets 29/58 €881,378 €737,032 -€144,346 -16.4%
Stocks and contracts in progress 3 €135,979 €133,980 -€1,999 -1.5%
Stocks 30/36 €135,979 €133,980 -€1,999 -1.5%
Amounts receivable within one year 40/41 €276,327 €312,745 +€36,418 +13.2%
Trade receivables 40 €156,516 €153,568 -€2,948 -1.9%
Other amounts receivable 41 €119,811 €159,177 +€39,366 +32.9%
Cash at bank and in hand 54/58 €456,788 €287,095 -€169,694 -37.1%
Deferred charges and accrued income 490/1 €12,284 €3,213 -€9,071 -73.8%
Total equity and liabilities 10/49 €904,109 €1,195,931 +€291,822 +32.3%
Equity 10/15 €257,232 €257,232 = 0.0%
Contributions 10/11 €62,000 €62,000 = 0.0%
Capital 10 €62,000 €62,000 = 0.0%
Issued capital 100 €62,000 €62,000 = 0.0%
Reserves 13 €195,232 €195,232 = 0.0%
Non-distributable reserves 130/1 €6,200 €6,200 = 0.0%
Legal reserve 130 €6,200 €6,200 = 0.0%
Distributable reserves 133 €189,032 €189,032 = 0.0%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €646,876 €938,698 +€291,822 +45.1%
Amounts payable after more than one year 17 €0 - =
Financial debts 170/4 €0 - =
Amounts payable within one year 42/48 €643,024 €933,335 +€290,311 +45.1%
Current portion of amounts payable after more than one year 42 €5,156 €25 -€5,131 -99.5%
Trade debts 44 €114,849 €114,070 -€779 -0.7%
Suppliers 440/4 €114,849 €114,070 -€779 -0.7%
Taxes, remuneration and social security 45 €13,402 €11,739 -€1,663 -12.4%
Taxes 450/3 €2,649 €1,097 -€1,552 -58.6%
Remuneration and social security 454/9 €10,754 €10,642 -€111 -1.0%
Other amounts payable 47/48 €509,617 €807,501 +€297,884 +58.5%
Accrued charges and deferred income 492/3 €3,852 €5,363 +€1,511 +39.2%
Remuneration, social security and pensions 62 €93,863 €76,925 -€16,938 -18.0%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,045 €28,483 +€15,439 +118%
Other operating charges 640/8 €555 €546 -€9 -1.6%
Gross operating margin 9900 €361,133 €330,511 -€30,622 -8.5%
Operating profit (loss) 9901 €253,671 €224,557 -€29,114 -11.5%
Financial income 75/76B €1,527 €1,044 -€483 -31.7%
Recurring financial income 75 €1,527 €1,044 -€483 -31.7%
Financial charges 65/66B €5,731 €5,549 -€182 -3.2%
Recurring financial charges 65 €5,731 €5,549 -€182 -3.2%
Profit (loss) for the period before taxes 9903 €249,467 €220,052 -€29,415 -11.8%
Income taxes 67/77 €23,240 €29,463 +€6,224 +26.8%
Profit (loss) for the period 9904 €226,227 €190,588 -€35,639 -15.8%
Profit (loss) for the period to be appropriated 9905 €226,227 €190,588 -€35,639 -15.8%

Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.